Pilihan
Thomson Fertility Embarks on In-Vitro Activation (IVA): New Hope for Women with Primary Ovarian Insufficiency or Diminished Ovarian Reserves
KOTA DAMANSARA, MALAYSIA - 8 October 2025 - Thomson Fertility is introducing In Vitro Activation (IVA), an advanced fertility technique offering new possibilities for women diagnosed with Primary Ovarian Insufficiency (POI) and diminished ovarian reserves (DOR) wishing to conceive with their own eggs.
Both conditions significantly reduce fertility potential, but research has shown that IVA can potentially increase live birth rates in women with POI and DOR from just 5% to up to 20%⁽¹⁾⁽²⁾.
The IVA procedure involves:
Key-hole surgery to remove a portion of ovarian tissue
Activating dormant follicles outside the body using specialised techniques and then,
Re-implanting the rejuvenated tissue into the ovarian bed. Patients are then given hormone therapy to stimulate follicle growth, where eggs can develop.
Thomson Fertility's collaboration with Professor Dr. Kazuhiro Kawamura of Juntendo University, Tokyo-the pioneer of IVA technology-further strengthens its role in raising awareness and expanding access to advanced fertility treatments in Malaysia.
Prof. Dr. Prasanna Supramaniam, Consultant in Obstetrics & Gynaecology, Fertility Specialist, Subspecialist in Reproductive Medicine, Minimally Invasive Gynaecological Surgeon and Associate Professor at Thomson Fertility, shared, "For women with POI or DOR, fertility struggles often feel like a closed door. IVA is a remarkable scientific step forward, creating opportunities for them to use their own eggs in their journey to parenthood. At Thomson Fertility, we believe it is important to highlight such advancements, so that women know there is hope."
Prof. Dr. Kazuhiro Kawamura, Juntendo University, added, "IVA is the culmination of years of research into ovarian tissue activation. Collaborations with centres like Thomson Fertility in Malaysia ensure that more patients can access and benefit from cutting-edge scientific research as they explore the possibilities in starting a family."
Ms. Lakshmi Menon, CEO of Thomson Fertility, said: "Celebrating life has always been at the heart of what we do. By raising awareness of IVA, we want women who have been told their chances are gone to know there is still hope. For Muslim women especially, being able to use their own eggs is a particularly pivotal opportunity. With over 8,000 IVF babies born from a single facility, Thomson Fertility continues to lead in fertility innovation, patient education and compassionate care - empowering women and couples across Malaysia with every chance to build the families they dream of."
The issuer is solely responsible for the content of this announcement.
Hashtags: #ThomsonFertility
.png)

Berita Lainnya
Laporan Hkbu Dan Elsevier Ungkap Pertumbuhan Global Penelitian Pengobatan Tiongkok, Serukan Standarisasi Integrasi Global
Bangkok Design Week 2026 Sets the Stage as Asia's Creative Hub
Coastline Wealth Management's Garrett Taylor Named a Top New York Best-in-State Wealth Advisor
Natascha Thomas Terpilih sebagai Presiden Baru Jaringan Internasional PDLN
Huawei Launches Comprehensive U6GHz Portfolio to Unlock 5G-A Potential and Pave the Way for 6G
EPIC 2025 Outdid Itself with Record-High 1,200 Applications
FBS Secures Three Prestigious FXDailyInfo Awards in 2025
Momentum Energy Gandeng Goodbye Gas untuk Wujudkan Rumah Listrik Ramah Lingkungan di Victoria
Thailand's Cafe Amazon Accelerates Global Expansion with Sustainability and Social Impact at the Core
HKSTP Manifesting 20 Latest BFSI Tech and Translation of R&D at Hong Kong FinTech Week x StartmeupHK Festival 2025
Global Superstar Ram Charan Unveils World's First Wax Figure At Madame Tussauds Singapore - Joined By His Beloved Dog Rhyme
Huawei Mengungkap Visi untuk Sinergi Submarine-Terestrial Synergy, Orkestrasi Optik-Cerdas